0001493152-23-032280.txt : 20230911
0001493152-23-032280.hdr.sgml : 20230911
20230911171805
ACCESSION NUMBER: 0001493152-23-032280
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230907
FILED AS OF DATE: 20230911
DATE AS OF CHANGE: 20230911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BUCHAN MELISSA JANE
CENTRAL INDEX KEY: 0001342502
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41159
FILM NUMBER: 231248483
MAIL ADDRESS:
STREET 1: 1920 MAIN STREET
STREET 2: SUITE 500
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immix Biopharma, Inc.
CENTRAL INDEX KEY: 0001873835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454869378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11400 WEST OLYMPIC BLVD.
STREET 2: SUITE 200
CITY: LOS ANGELES
STATE: CA
ZIP: 90064
BUSINESS PHONE: (888) 958-1084
MAIL ADDRESS:
STREET 1: 10573 W. PICO BLVD.
STREET 2: #58
CITY: LOS ANGELES
STATE: CA
ZIP: 90064
4
1
ownership.xml
X0508
4
2023-09-07
0
0001873835
Immix Biopharma, Inc.
IMMX
0001342502
BUCHAN MELISSA JANE
C/O IMMIX BIOPHARMA, INC.
11400 WEST OLYMPIC BLVD., SUITE 200
LOS ANGELES
CA
90064
1
0
0
0
0
Common Stock
2023-09-07
4
P
0
20000
2.4613
A
20000
D
This figure is the weighted average sales price of multiple trades ranging from $2.39 to $2.49 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request.
/s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan
2023-09-11